
About Me
Peter B. Bach, Director of Memorial Sloan Kettering’s Center for Health Policy and Outcomes, is a physician, epidemiologist, researcher, and respected healthcare policy expert whose work focuses on the cost and value of anticancer drugs. Dr. Bach is leading efforts to increase understanding of the US drug development process and develop new models for drug pricing that include value to patients as a critical component. As the cost of specialty drugs continues to grow, he argues that prices are no longer rational, and a better pricing system could increase patient access to life-saving medications at lower costs while spurring innovation.